DNMIVD: DNA methylation interactive visualization database

Abstract Aberrant DNA methylation plays an important role in cancer progression. However, no resource has been available that comprehensively provides DNA methylation-based diagnostic and prognostic models, expression–methylation quantitative trait loci (emQTL), pathway activity-methylation quantitative trait loci (pathway-meQTL), differentially variable and differentially methylated CpGs, and survival analysis, as well as functional epigenetic modules for different cancers. These provide valuable information for researchers to explore DNA methylation profiles from different aspects in cancer. To this end, we constructed a user-friendly database named DNA Methylation Interactive Visualization Database (DNMIVD), which comprehensively provides the following important resources: (i) diagnostic and prognostic models based on DNA methylation for multiple cancer types of The Cancer Genome Atlas (TCGA); (ii) meQTL, emQTL and pathway-meQTL for diverse cancers; (iii) Functional Epigenetic Modules (FEM) constructed from Protein-Protein Interactions (PPI) and Co-Occurrence and Mutual Exclusive (COME) network by integrating DNA methylation and gene expression data of TCGA cancers; (iv) differentially variable and differentially methylated CpGs and differentially methylated genes as well as related enhancer information; (v) correlations between methylation of gene promoter and corresponding gene expression and (vi) patient survival-associated CpGs and genes with different endpoints. DNMIVD is freely available at http://www.unimd.org/dnmivd/. We believe that DNMIVD can facilitate research of diverse cancers.

[1]  Yan Zhang,et al.  Lnc2Meth: a manually curated database of regulatory relationships between long non-coding RNAs and DNA methylation associated with human disease , 2017, Nucleic Acids Res..

[2]  Zhao Zhang,et al.  Pancan-meQTL: a database to systematically evaluate the effects of genetic variants on methylation in human cancer , 2018, Nucleic Acids Res..

[3]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[4]  Preeti Sharma,et al.  Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease , 2016, Tumor Biology.

[5]  Andrew E. Teschendorff,et al.  A systems-level integrative framework for genome-wide DNA methylation and gene expression data identifies differential gene expression modules under epigenetic control , 2014, Bioinform..

[6]  Karin Milde-Langosch,et al.  The Fos family of transcription factors and their role in tumourigenesis. , 2005, European journal of cancer.

[7]  Li Wang,et al.  Cooperative genomic alteration network reveals molecular classification across 12 major cancer types , 2016, Nucleic acids research.

[8]  SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas , 2016, Clinical Epigenetics.

[9]  J. Vilo,et al.  MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. , 2018, Epigenomics.

[10]  Shyr Yu,et al.  HACER: an atlas of human active enhancers to interpret regulatory variants , 2018, Nucleic Acids Res..

[11]  A. Frigessi,et al.  DNA methylation at enhancers identifies distinct breast cancer lineages , 2017, Nature Communications.

[12]  S. Lam,et al.  ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[15]  Tieliu Shi,et al.  Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis , 2019, Epigenetics.

[16]  Wenbao Han,et al.  Biological data processing based on bio-processor unit (BPU), a new concept for next generation computational biology , 2018, Science China Life Sciences.

[17]  Weida Tong,et al.  QuaPra: Efficient transcript assembly and quantification using quadratic programming with Apriori algorithm , 2019, Science China Life Sciences.

[18]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[19]  W. Xiao,et al.  Sequencing XMET genes to promote genotype-guided risk assessment and precision medicine , 2019, Science China Life Sciences.

[20]  P. Kapur,et al.  A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma , 2015, Nature Communications.

[21]  Adrian V. Lee,et al.  An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics , 2018, Cell.

[22]  J. Martens,et al.  A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence , 2016, bioRxiv.

[23]  Philippe Bardou,et al.  jvenn: an interactive Venn diagram viewer , 2014, BMC Bioinformatics.

[24]  J. Castle,et al.  expression data: the tissue distribution of human pathways , 2006 .

[25]  Eric Jones,et al.  SciPy: Open Source Scientific Tools for Python , 2001 .

[26]  Lianghong Zheng,et al.  DNA methylation markers for diagnosis and prognosis of common cancers , 2017, Proceedings of the National Academy of Sciences.

[27]  Matthias W. Beckmann,et al.  DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer , 2016, Nature Communications.

[28]  V. Govorun,et al.  Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips , 2013, Epigenetics.

[29]  F. Jänicke,et al.  C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma , 2008, British Journal of Cancer.